| VLTO |
Report |
Adjusted EPS |
BEAT |
pred ~$1.02 vs. cons $1.00 |
MEDIUM |
| VLTO |
Report |
Revenue |
IN-LINE |
pred ~$1.45B vs. cons $1.44B |
MEDIUM |
| VLTO |
Report |
Core sales growth |
BEAT |
pred ~4.1% vs. cons 4.0% |
MEDIUM |
| VLTO |
Guide |
FY26 adjusted EPS guidance |
UNCHANGED |
guide ~$4.24 midpoint vs. cons $4.25 (FY26) |
MEDIUM |
| VLTO |
Guide |
FY26 core sales growth guidance |
UNCHANGED |
guide ~3.75% midpoint vs. cons 3.8% (FY26) |
MEDIUM |
| VLTO |
Guide |
FY26 adjusted operating-margin expansion |
UNCHANGED |
guide ~25 bps vs. cons 25 bps (FY26) |
MEDIUM |
| VLTO |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.5% |
— |
MEDIUM |
| VLTO |
Return |
5-day cumulative residual |
+0.5% (FADE) |
A modest ~$0.02 EPS beat and ~10 bps core-growth upside should support an initial positive response, but unchanged FY26 EPS guidance of ~$4.24 versus ~$4.25 consensus leaves limited out-period revision upside; implied second-half EPS remains ~ $2.10 versus ~ $2.12 expected. |
MEDIUM |